BioSig Technologies, Inc.
  • Home
  • About BioSig
    • Overview
    • Leadership
    • Partnerships
  • PURE EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

December 14, 2022

BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

December 6, 2022

BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology

October 24, 2022

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

October 12, 2022

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

October 7, 2022

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

September 22, 2022

BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth

August 30, 2022

BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence

August 24, 2022

BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022

August 17, 2022

BioSig Sees Positive Momentum from Sales Pipeline Growth

August 16, 2022
rss_feed News RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...33
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    Twitter linkedin Facebook
    © 2023 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap